LATEST
Silgan / Trivium: minority stakenewBF International Best Fields Best Food / DiagramnewOpenWorld agreed to acquire Blocksight HoldingsnewMerck KGaA agreed to acquire Silence TherapeuticsLarry A. Powalisz / Adia LabsTTM Technologies / Ophir® Optics businessTradeweb Markets agreed to acquire Trumid HoldingsCentrus Energy / Westerman HoldingsTCGX Acquisition / TriGemX BioArlington Capital Partners / Gooch & HousegoJanus Henderson Investors agreed to acquire four mutual funds managed by Nicholas CompanyPlatinum Equity / Trime: majority stake
Open App
Agreement signedAgreed 22 Jan 2024

Aventis Inc. /
Inhibrx, Inc.

Aventis Inc. agrees to buy Inhibrx, Inc.

Buy side: Aventis Inc.
Buy sideAventis Inc.
Target: Inhibrx, Inc.
TargetInhibrx, Inc.
Source · 22 Jan 2024Source-verified
See the source
Buy side: Aventis Inc.
Buy sideAventis Inc.
Target: Inhibrx, Inc.
TargetInhibrx, Inc.
01 / BuyerAventis Inc.
02 / TargetInhibrx, Inc.
Source-verified
01

What happened

Aventis Inc. agreed to acquire Inhibrx, Inc. for approximately $2 billion, according to a filing dated May 30, 2024.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Aventis Inc. agrees to buy Inhibrx, Inc.

This document is the source for the companies, stage, figure and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by the source

    The source this page is built from.

    Source-verified

  2. Announced

    The source this page is built from.

    Source-verified

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request an inviteAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.